Free Trial
ETR:CCAP

CORESTATE Capital (CCAP) Stock Price, News & Analysis

CORESTATE Capital logo
€0.40 0.00 (0.00%)
(As of 11/22/2024 ET)

About CORESTATE Capital Stock (ETR:CCAP)

Key Stats

Today's Range
€0.38
€0.40
50-Day Range
€0.38
€0.43
52-Week Range
€0.26
€0.76
Volume
280 shs
Average Volume
N/A
Market Capitalization
$13.74 million
P/E Ratio
N/A
Dividend Yield
621.89%
Price Target
N/A
Consensus Rating
N/A

Company Overview

CORESTATE Capital Holding S.A. is a real estate investment firm specializing in investments in small to medium sized residential portfolios and commercial real estate markets. The firm seeks to invest in an "anti-cyclical" manner in Europe and expand its club-style deals from purely opportunistic to core-plus and value-add investments. The firm offers investment products in real estate funds, co-investments, and club deals. It prefers to invest in Central Europe, Austria, Switzerland, and Germany. CORESTATE Capital Holding S.A. was founded in 2006 and is based in Luxembourg, Luxembourg with additional offices in Zug, Switzerland; London, United Kingdom; Frankfurt, Germany; and Singapore. CORESTATE Capital Holding S.A. operates as a subsidiary of Flygon Holding LLC.

Receive CCAP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CORESTATE Capital and its competitors with MarketBeat's FREE daily newsletter.

CCAP Stock News Headlines

Corestate Capital Holding SA
Wells Fargo Sticks to Its Hold Rating for Crescent Capital BDC (CCAP)
Let’s be blunt
Let me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)!
KBW Releases a Buy Rating on Crescent Capital BDC (CCAP)
See More Headlines

CCAP Stock Analysis - Frequently Asked Questions

CORESTATE Capital's stock was trading at €0.45 at the beginning of 2024. Since then, CCAP shares have decreased by 10.7% and is now trading at €0.40.
View the best growth stocks for 2024 here
.

Based on aggregate information from My MarketBeat watchlists, some other companies that CORESTATE Capital investors own include bluebird bio (BLUE), Cisco Systems (CSCO), AbbVie (ABBV), Allena Pharmaceuticals (ALNA), Aravive (ARAV), Athersys (ATHX) and Atara Biotherapeutics (ATRA).

Industry, Sector and Symbol

Industry
Real Estate Services
Sub-Industry
Financial Services
CIK
N/A
Fax
N/A
Employees
446
Year Founded
N/A

Profitability

Net Income
$-779,800,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$110.90 million
Cash Flow
€0.68 per share
Book Value
€1.16 per share

Miscellaneous

Free Float
N/A
Market Cap
$13.74 million
Optionable
Not Optionable
Beta
1.03
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report

This page (ETR:CCAP) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners